| Issue Date | Title | Author(s) |
| 2019 | Carbamylated darbepoetin in combination with ethoxydol attenuates doxorubicin-induced cardiomyopathy in rats | Kolesnichenko, P. D.; Popova, I. A.; Sheblykin, D. V.; Alhamzah Muhi Aldeen Azeez; Soldatov, V. O.; Lazareva, G. A.; Stepchenko, A. A. |
| 2020 | Comparative study of the pharmacological effects of Venarus Plus, Venarus, and Detralex on L-NAME-induced endothelial dysfunction, venous tone and platelet aggregation | Lukyanova, Y. S.; Gureev, V. V.; Kolesnichenko, P. D.; Danilenko, L. M.; Gudyrev, O. S.; Pokrovskaya, T. G. |
| 2016 | Development perspectives of new generation medications based on the redox system regulators | Shahmardanova, S. A.; Gulevskaya, O. N.; Galenko-Yaroshevsky, P. A.; Kolesnichenko, P. D. |
| 2018 | Effect of carbamylated darbepoetin administration at different doses on the thymus and spleen structure of rats | Tverskoi, A. V.; Zhuchenko, M. A.; Kolesnichenko, P. D.; Morozova, E. N.; Morozov, V. N. |
| 2018 | Evaluation of carbamylated darbepoetin acute toxicity | Kolesnichenko, P. D.; Gudyrev, O. S.; Zhuchenko, M. A.; Zhernakova, N. I.; Faitelson, A. V. |
| 2018 | Evaluation of pharmacological correction of L-NAME-induced endothelial dysfunction, platelet aggregation and venous tone with diosmin detralex 1000 mg | Lukyanova, Y. S.; Kolesnichenko, P. D.; Gureev, V. V.; Zhilinkova, L. A. |
| 2017 | Experimental rationale for the use of fluids with different redox potential as a basis for infusion therapy | Kovalenko, I. V.; Kolesnichenko, P. D. |
| 2018 | Influence of the drug Detralex on calcium ion-dependent smooth muscle contractility, function of an endothelium and aggregation of thrombocytes in the conditions of experimental modeling of endothelial dysfunction | Lukyanova, Y. S.; Kolesnichenko, P. D.; Hoshchenko, Y. A.; Shutov, V. I.; Povetkin, S. V. |
| 2018 | Morphology of the rat’s brain in four vessels model of ischemic stroke after administration of carbamylated darbepoetin | Tverskoy, A. V.; Kolesnichenko, P. D.; Shcheblykina, O. V.; Gorbunova, N. S.; Morozov, V. N. |
| 2018 | Natality and mortality with reduced RED-OX potential drinking water | Kolesnichenko, P. D.; Reznikov, K. M.; Efremova, O. A.; Zhernakova, N. I.; Stepchenko, A. A. |
| 2019 | Neuroprotective effects of taurine and 3-hydroxypyridine derivatives in the intracerebral hemorrhage model in rats | Nesterova, N. I.; Shcheblykina, O. V.; Kolesnichenko, P. D.; Nesterov, A. V.; Shcheblykin, D. V. |
| 2018 | Pharmacological screening antihypoxic and cytoprotective properties of mexidol and analogs of human erythropoietin in cultured leukocytes of pigs | Kolesnichenko, P. D.; Zhuchenko, M. A.; Reznikov, K. M.; Efremova, O. A.; Zhernakova, N. I. |
| 2018 | Potentiating interaction of ethoxydol and rosuvastatin in an experimental model of Langendorf-isolated rat heart total ischemia-reperfusion | Kolesnichenko, P. D.; Soldatov, V. O.; Puchenkova, O. A.; Dudchenko, O. V.; Miller, E. S. |
| 2017 | Search of new pharmaceuticals on the basis of darbepoetin in the treatment of ischemic stroke: review of literature | Reznikov, K. M.; Gorbunova, N. S.; Kolesnichenko, P. D.; Tverskoy, A. V.; Kostina, D. A. |
| 2019 | Study to Investigate the anti-inflammatory effect of Codelac® Broncho with Thymus Serpyllum (elixir) in comparison with reference drug Fenspiride (syrup) using accute carrageenan-induced paw inflammation model | Kolesnichenko, P. D.; Peresypkina, A. A.; Poromov, A. A.; Kareva, E. N.; Tverskoi, A. V. |
| 2019 | The cardio- and endothelial protective effects of ethyl methyl hydroxyl pyridine malate in modeling L-name induced nitric oxide deficiency | Kolesnichenko, P. D.; Shcheblykin, D. V.; Demidenko, A. N.; Reznikov, K. M.; Alhamzah Muhi Aldeen Azeez; Zhuchenko, M. A.; Demchenko, S. A. |
| 2018 | The value changes redox system the body fluid media for life processes and the action of drugs | Kolesnichenko, P. D.; Reznikov, K. M.; Zhhernakova, N. I.; Stepchenko, A. A.; Popova, I. A. |
